Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
LIVE ATTENUATED IB VIRUS STRAIN MA5
Intervet Ireland Limited
QI01AD07
LIVE ATTENUATED IB VIRUS STRAIN MA5
Unknown
Lyophilisate for solution
POM
Fowl - Chicken
Avian infectious bronchitis virus vaccine
Immunological - Live Vaccine
Authorised
2003-02-19
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB Ma5 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _______________________________ * EID 50 = 50% Embryonic Infective Dose 3 PHARMACEUTICAL FORM Lyophilisate for suspension. Vials: off-white/cream coloured pellet Cups: off-white predominantly sphere shaped 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES To reduce mortality and clinical signs of Massachusetts or serologically related types of infectious bronchitis. A single vaccination gives protective immunity that lasts at least through the normal broiler rearing period (5 – 7 weeks). Where appropriate, e.g. in layers and breeders, revaccination at approximately 6 week intervals is advised. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The vaccine virus may spread from vaccinates to non-vaccinated birds and appropriate care should be taken to separate vaccinates from non-vaccinates. ACTIVE SUBSTANCE(S) PER DOSE Live avian infectious bronchitis virus strain Ma5 10 3.5 EID 50 * EXCIPIENTS For the full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 26/08/2016_ _CRN 7021825_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Only healthy chickens should be vaccinated. Special precautions to be taken by the person administering the veterinary medicinal product to animals Wash and disinfect hands after use. When spraying the vaccine, to avoid hay-fever like reactions in some individuals, operators should wear respiratory and eye protection conforming to current European Standards. 4.6 ADVERSE REACTIONS (FREQUENCY AND Přečtěte si celý dokument